In summary, we demonstrated that TRIM65 serves as a central oncogene through the activation of YAP1 and up‐regulation of UDP‐GlcNAc and FFA levels, thus promoting the tumor immunosuppressive microenvironment in HCC. This evidence concerns the gene YAP1 and hepatocellular carcinoma.